Confusion and Lightheadedness Related to Calcium Channel Blocker Toxicity

  • Deepak Chandra University of Arkansas for Medical Sciences, Arkansas, USA
  • Yogita Rochlani University of Arkansas for Medical Sciences, Arkansas, USA
  • Deepa Jayakrishnan Arkansas, USA
  • Bijay Nair Roseville, California
Keywords: Calcium Channel Blocker Toxicity, Diltiazem Toxicity, Bradycardia

Abstract

Calcium channel blockers are commonly used drugs to control blood pressure and heart rate. These drugs can significantly depress cardiac inotropy and chronotropy at high doses, with adverse effects. We present the case of a woman, recently started on diltiazem for hypertension, who presented with severe hypotension and bradycardia. Electrocardiogram at admission, revealed a junctional rhythm. She was initially resuscitated with intravenous fluids and atropine boluses without any response. Septic workup, cardiac biomarkers, thyroid stimulating hormone and cortisol levels were normal. Hemodynamics gradually improved on glucagon and dopamine drip. She reverted back to normal sinus rhythm in about six hours. This case illustrates the importance of medication reconciliation in patients.

Author Biographies

Deepak Chandra, University of Arkansas for Medical Sciences, Arkansas, USA

Department of Internal Medicine

Yogita Rochlani, University of Arkansas for Medical Sciences, Arkansas, USA

Department of Internal Medicine

Deepa Jayakrishnan, Arkansas, USA

 Harmony Health Clinic

Bijay Nair, Roseville, California

Division of Oncology, Kaiser-Permanente Medical Center

Published
2020-03-23
How to Cite
Chandra, D., Rochlani, Y., Jayakrishnan, D., & Nair, B. (2020). Confusion and Lightheadedness Related to Calcium Channel Blocker Toxicity. Kerala Medical Journal, 13(1), 21-22. https://doi.org/10.52314/kmj.2020.v13i1.586
Section
Case Series / Case Report